DB15812InvestigationalProtein Based Therapies
COVID-19 convalescent plasma is currently being acquired from recovered COVID-19 patients and used as prophylaxis for the virus. This therapeutic concept was applied to the development of V-SARS, which heat... Immunitor Inc., the sponsor, is currently testing this oral vaccine for immunogenicity in 20 healthy volunteers in a Phase 1 clinical trial (NCT04380532).
- Also known as
- Heat inactivated convalescent plasma
- Code names
- V-SARS
What you can answer from here — as of September 06, 2020
Which companies are running trials of V-SARS, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account